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Abstract: Reported herein is the one-pot synthesis of trifluoromethylated amines at room temperature using the bench-stable (Me 4 N)SCF 3 reagent and AgF.T he method is rapid, operationally simple and highly selective.I tp roceeds via af ormal umpolung reaction of the SCF 3 with the amine,g iving quantitative formation of thiocarbamoyl fluoride intermediates within minutes that can readily be transformed to N-CF 3 .T he mildness and high functional group tolerance render the method highly attractive for the late-stage introduction of trifluoromethyl groups on amines,a sd emonstrated herein for arange of pharmaceutically relevant drug molecules.
Fluorination confers molecules with improved properties and function, affecting lipophilicity,solubility,conformational and metabolic stability features that impact numerous branches of chemistry,i ncluding the agrochemical and pharmaceutical arenas.
[1] While up to 40 %o fa ll active compounds feature at least one fluorine atom, nitrogen makes up for an even greater abundance of 80 %. [2] In view of the widespread dissemination of both elements in pharmaceuticals,i ti ss omewhat puzzling that their combined functionality,that is,trifluoromethyl amines,are scarcely investigated to date.T his might be ac onsequence of the lack of safe, general and high-yielding methodology to access these compounds as well as encountered difficulties in their purifications (see Figure 1) . [3] Thel atest advances in the methodological repertoire include the direct N-trifluoromethylation of certain amines,n itriles and azoles with electrophilic [4] or radical-based reagents, [5] posing continued challenges in terms of generality and late-stage synthetic applications to compounds with incompatible additional functionality.Alternatively,N-CF 3 compounds can be made in atwostep sequence from free amines via oxidative transformations of dithiocarbamates.
[6] Access to the latter can be non-trivial however with respect to functional group compatibility,a s their syntheses generally require strong base,a lkylating or toxic reagents. [7] Amild, safe and operational simple synthetic route to N-CF 3 compounds would hence be desirable and may enable numerous avenues in chemical and biomedical research. For example,t he frequently encountered facile oxidation of amines in metabolic processes should be less pronounced under N-CF 3 modification. [8] In addition, our calculations of selected drug molecules indicate similar conformational preferences but increased logP values for N-CF 3 vs.N -Me. [9] Moreover,apromising isolated study found the N-CF 3 analogue of floxacin to retain similar antibacterial activities as its methylated counterpart. [10] We herein demonstrate the rapid and selective formation of awide range of trifluoromethylated amines from secondary amines.T he high-yielding,o ne-pot strategy is based on apolarity inversion and in situ formation of athiocarbamoyl fluoride intermediate using the bench-stable (Me 4 N)SCF 3 reagent.
As part of our ongoing mechanistic and methodological program [11] that also focusses on the generation of fluorinecontaining compounds, [12] we recently developed metal-catalyzed C À SCF 3 bond formation protocols of aryl (pseudo)-halides,u sing the bench-stable "SCF 3 À "s ource (Me 4 N)SCF 3 . [13, 14] During these investigations,w ee ncountered the unexpected formation of ac hallenging class of compounds,t hat is,athiocarbamoyl fluoride.T he subjection of one equivalent of (Me 4 N)SCF 3 to N-methylaniline in toluene at room temperature remarkably gave rise to facile and quantitative formation of N-methyl-N-phenylthiocarbamoyl fluoride 1a within minutes without any need for additional reagents or catalysts (see Scheme 1). Although thiocarbamoyl chlorides are well known and widely reported, interestingly,t he fluoride equivalent has seen much less precedence. [15] Thefew reported syntheses relied on the use of highly toxic and strongly electrophilic reagents. [16] As such, our discovery constitutes ac onsiderable advance,b eing safe, convenient, rapid and utilizing abench-stable solid as the sole reaction partner for quantitative transformation within minutes.T ot est the generality,w ee xplored av ariety of additional secondary amines for their reactivities with (Me 4 N)SCF 3 .S cheme 1s hows two additional examples of isolated thiocarbamoyl fluorides (and Tables 1a nd 2r eport their follow-up usage). Notably,t hrough the addition of hexane after 10 min reaction time,a ll side-products are precipitated, allowing facile isolation of the thiocarbamoyl fluoride upon filtration, if desired.
Given this intriguing and non-obvious reactivity of two nucleophiles (R 2 NH and CF 3 S À )t og enerate the highly electrophilic thiocarbamoyl fluoride quantitatively,w es et out to explore this transformation in greater detail. On first sight, ar easonable scenario would appear to be the in situ generation of F 2 C = Su pon fluoride elimination, [17] which could then serve as an electrophile to the amine.H owever, dissolved (Me 4 N)SCF 3 salt in MeCN neither generated F 2 C=S by itself nor under the addition of asmall amount of water. [18] Furthermore,ifgenerated F 2 C=Swere to trigger the observed reactivity,w ew ould also expect to see transformation with nucleophiles other than secondary amines.H owever,s ubjection of the (Me 4 N)SCF 3 reagent to tertiary amines or phosphines did not give rise to any reaction, [19] indicating potential for selectivity which would otherwise not be given with standard electrophiles that would preferentially select for the most nucleophilic site (Scheme 1). In our case, selectivity for the "heteroatom-H" site appears to be given.
We next investigated oxygen-based nucleophiles.
[17b] We observed that the reaction of phenol with (Me 4 N)SCF 3 gives rapid formation of the thiocarbonate species ROC(S)OR within minutes.S imilarly,a lso rather weakly nucleophilic alcohols,such as 2,2,2-trifluoroethanol (N = 1.11 according to Mayrss cale [20] )o rh exafluoroisopropanol (N = À1.93) formed the corresponding thiocarbonates upon subjection to (Me 4 N)SCF 3 .O nt he other hand, the arguably more nucleophilic 4-(trifluoromethyl)phenoxide did not markedly react with (Me 4 N)SCF 3 ,s howing only traces of product over the course of 15 ha tr oom temperature (see Scheme 1, bottom).
These results clearly indicate that in contrast to established transformations to access these and related compound classes,t he nucleophilicity of the to be functionalized heteroatom is not the decisive reactivity factor, therefore offering ap latform for distinct selectivities and functional group tolerance in the context of late-stage applications of this methodology.
That said, we next set out to further transform this valuable intermediate to trifluoromethyl amines.W ea nticipated that the distinct selectivity imposed in the first reaction step should ultimately translate to the final N-CF 3 compounds.
Building on Ty rrasr eport that described the AgFmediated conversion of ad iethylcarbamoyl fluoride to N-CF 3 , [21] we subsequently investigated the feasibility of this protocol to convert awider range of thiocarbamoyl fluorides, including those generated in situ under our conditions.Mixing N-methylaniline in acetonitrile with (Me 4 N)SCF 3 led to the quantitative formation of the corresponding thiocarbamoyl fluoride within 10 minutes at room temperature,asjudged by quantitative 19 F-NMR analysis of the reaction mixture. Subsequent direct addition of AgF (3 equiv) to the same mixture gave complete conversion to the corresponding trifluoromethylated amine 1 in Table 1w ithin two hours. Ther eaction between AgF and the thiocarbamoyl fluoride was found to proceed smoothly at room temperature or higher temperature (50 8 8C). [22] No side-products,for example, arising from aR itter-type reaction as commonly observed under electrophilic trifluoromethylation of amines, [4b] were detected.
Notably,t he only by-products generated in this one-pot two-step sequence are salts [(Me 4 N)HF 2 and Ag 2 S].T hose can readily be precipitated from the reaction mixture via the addition of low polarity solvents,s uch as hexane or pentane, leaving the desired N-CF 3 target compound as the only product dissolved in the organic phase (MeCN). Thus,o nly filtration and solvent removal are required to isolate the desired N-CF 3 compounds.F or more volatile products,w e identified that it is also possible to use the lower boiling solvent CH 2 Cl 2 as reaction medium. Although AgF is not soluble in CH 2 Cl 2 ,s onication of the reaction mixture mitigates this and the trifluoromethylamines are generated equally effectively.
This one-pot protocol therefore presents ac onvenient, safe and high-yielding route to trifluoromethylamines, and we subsequently set out to investigate its full potential. Table 1 presents an overview of the studied amines.W ef ound our protocol to be compatible with aromatic as well as aliphatic secondary amines,g enerating the corresponding N-CF 3 products in excellent yields (98-81 %). Electron-poor and rich amines were coupled with the same efficiency (see Table 1 ). Exclusive selectivity for the NH site and ah igh functional group tolerance were observed. Halogens (6, 11, 18), ester (2, 5, 7, 14, 17) , nitrile (4), nitro (3, 15) , amide (13), sulfonyl (19) , methoxy (12, 16)a sw ell as ah eterocycle (18) were all tolerated. Twop rotected amino acids,t hat is,t he glycine (7)a nd proline (2)derivatives,were also successfully synthesized. As such, the presented methodology constitutes as ignificant improvement to previous protocols in terms of operational simplicity and generality.
As afurther test of our newly developed methodology for pharmaceutical and agrochemical applications,w en ext investigated nitrogen-containing drug molecules of greater complexity.W esuccessfully N-trifluoromethylated tetracaine 20,awidely used anesthetic,i n9 7% yield (Table 2) . [23] Similarly,t here are numerous N-Me containing drugs on the market, and we therefore also investigated the feasibility to synthesize their N-CF 3 bioisosteres. [24] In this context, we primarily focused on pharmaceuticals that are listed on the "WHO Model List of Essential Medicines" (a list containing the most important medications required in any basic health system).
[25] We prepared the N-CF 3 analogue of Sildenafil 21 in high yield (88 %), the most widely used drug against erectile dysfunction (Viagra ), [26] the antifungal agents terbinafine 22 (in 95 %), [27] and naftifine 23 (88 %) as well as amitriptyline 24 (98 %) [28] that finds use in the treatment of mental illnesses (see Table 2 ). We were pleased to obtain high yields in all cases,d emonstrating the scope and applicability of this protocol in ap harmaceutical context, as heterocycles, tertiary amines,alkynes and alkenes were well tolerated.
In summary,w er eported ac onvenient, safe and operationally simple one-pot protocol for the rapid and mild trifluoromethylation of secondary amines.T he readily accessible bench-stable (Me 4 N)SCF 3 salt formally serves as CF 3 source via initial reaction between the SCF 3 -anion and the amine.U pon umpolung ar arely encountered and valuable thiocarbamoyl fluoride intermediate is generated quantitatively in situ that can subsequently be converted to the corresponding N-CF 3 compounds upon reaction with AgF. Thepurification consists solely of precipitation of the salt byproducts with non-polar solvent, followed by filtration. The umpolung strategy allowed distinct selectivities in trifluoromethylation which is not governed by nucleophilicity,b ut instead by the availability of an "N-H" unit. As such, the protocol displays aw ide functional group tolerance,a nd was demonstrated to be compatible with carbonyl, alkene,alkyne, tertiary amine,nitrile,nitro,heterocycles as well as protected amino acids and relevant pharmaceuticals.
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[a] Reaction conditions: Amine (0.2 mmol), (Me 4 N)SCF 3 (46 mg, 0.26 mmol), AgF (76 mg, 0.6 mmol) solvent (1.5 mL).
